Discovery of lung cancer mutations responsive to targeted therapies, immunotherapies
Monday, May 9, 2016 - 12:30
in Health & Medicine
A number of new driver mutations in lung cancer cells has been discovered that may be responsive to genomically targeted therapies and to immunotherapy.